Ayala Corporation - AYALY

AYALY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
AYALY	-10.6	0	-23.4	-22.3	0	-11.1	-42.9	-36.4	-40.5	-8.7
S&P 500	1.0	1.5	1.1	2.3	8.9	23.6	33.8	80.6	196.5	33856.2

Compare AYALY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	AYALY
name	Ayala Corporation
price	9.6
changes percentage	-10.6145
change	-1.14
day low	9.6
day high	10.74
year high	59.99
year low	9.6
market cap	5986531200
price avg 50	11.52
price avg 200	10.6884
exchange	PNK
volume	29
avg volume	30
open	10.74
previous close	None
eps	1.05
pe	9.14
earnings announcement	2025-03-12T10:59:00.000+0000
shares outstanding	623597000
timestamp	2025-01-17 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 41.7%

Overall Quarterly Financial Health: 42.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	341897736000	270515384000	26.39
gross profit	122065696000	59946660000	103.62
gross profit ratio	0.36	0.22	61.11
research and development expenses	477826000	229827000	107.91
operating expenses	36321751000	27430648000	32.41
interest income	8521640000	1076374000	691.70
interest expense	28217952000	25884106000	9.02
ebitda	107455117000	93643915000	14.75
ebitdaratio	0.31	0.35	-10.95
operating income	84861390000	79798299000	6.34
operating income ratio	0.25	0.29	-15.86
net income	38073084000	45873931000	-17.00
net income ratio	0.11	0.17	-34.33
eps	56.06	74.06	-24.30

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 341,898 million in 2023 from 270,515 million in 2022 representing a change of 26.39%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 122,066 million in 2023 from 59,947 million in 2022 representing a change of 103.62%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 478 million in 2023 from 230 million in 2022 representing a change of 107.91%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 84,861 million in 2023 from 79,798 million in 2022 representing a change of 6.34%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 36,322 million in 2023 from 27,431 million in 2022 representing a change of 32.41%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 107,455 million in 2023 from 93,644 million in 2022 representing a change of 14.75%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 38,073 million in 2023 from 45,874 million in 2022 representing a change of -17.0%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 56.06 in 2023 from 56.06 in 2022 representing a change of -24.3%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	76237519000	92672927000	-17.73
gross profit	21813160000	34632665000	-37.02
gross profit ratio	0.29	0.37	-23.44
research and development expenses	0	0	NaN
operating expenses	21813160000	16195847000	34.68
interest income	3037060000	3043242000	-0.20
interest expense	8759167000	8271126000	5.90
ebitda	32406585000	22773177000	42.30
ebitdaratio	0.43	0.25	72.98
operating income	11667674000	0	NaN
operating income ratio	0.15	0	NaN
net income	11678264000	9213701000	26.75
net income ratio	0.15	0.1	54.07
eps	0	13.58	-100.00

Overall Score of Quarterly Income Statement

0.29 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 76,238 million in 2024Q3 from 92,673 million in 2024Q2 representing a change of -17.73%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 21,813 million in 2024Q3 from 34,633 million in 2024Q2 representing a change of -37.02%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 21,813 million in 2024Q3 from 16,196 million in 2024Q2 representing a change of 34.68%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Net Income: Net income decreased to 11,678 million in 2024Q3 from 9,214 million in 2024Q2 representing a change of 26.75%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0 in 2024Q3 from 0 in 2024Q2 representing a change of -100.0%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 32,407 million in 2024Q3 from 22,773 million in 2024Q2 representing a change of 42.3%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 11,668 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. The increase in operating income indicates better operational performance and increased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	1608713290000	1478545136000	8.80
total liabilities	933771929000	883246092000	5.72
total equity	674941361000	595299044000	13.38
cash and cash equivalents	74784222000	73847371000	1.27
short term investments	8733903000	14878175000	-41.30
long term investments	391297249000	343471631000	13.92
total current assets	575495486000	541782240000	6.22
total non current assets	1033217804000	936762896000	10.30
total current liabilities	349362933000	309014757000	13.06
total non current liabilities	584408996000	574231335000	1.77
common stock	31475111000	31719396000	-0.77
retained earnings	297882907000	267836258000	11.22
total debt	620549273000	614328049000	1.01

Overall Score of Annual Balance Sheet

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,608,713 million in 2023 from 1,478,545 million in 2022 representing a change of 8.8%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 674,941 million in 2023 from 595,299 million in 2022 representing a change of 13.38%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 74,784 million in 2023 from 73,847 million in 2022 representing a change of 1.27%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 575,495 million in 2023 from 541,782 million in 2022 representing a change of 6.22%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 297,883 million in 2023 from 267,836 million in 2022 representing a change of 11.22%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 933,772 million in 2023 from 883,246 million in 2022 representing a change of 5.72%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 8,734 million in 2023 from 14,878 million in 2022 representing a change of -41.3%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 349,363 million in 2023 from 309,015 million in 2022 representing a change of 13.06%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 31,475 in 2023 from 31,719 in 2022 representing a change of -0.77%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 620,549 million in 2023 from 614,328 million in 2022 representing a change of 1.01%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	1716041291000	1678647387000	2.23
total liabilities	991167068000	972986315000	1.87
total equity	724874223000	708609051000	2.30
cash and cash equivalents	72057965000	78759593000	-8.51
short term investments	10489705000	7964088000	31.71
long term investments	418283848000	398024207000	5.09
total current assets	573219177000	591654746000	-3.12
total non current assets	1142822114000	1089940619999	4.85
total current liabilities	365734168000	369096974000	-0.91
total non current liabilities	625432900000	603889341000	3.57
common stock	31788574000	31478227000	0.99
retained earnings	329819864000	318532234000	3.54
total debt	676201677000	644298863000	4.95

Overall Score of Quarterly Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,716,041 million in 2024Q3 from 1,678,647 million in 2024Q2 representing a change of 2.23%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 724,874 million in 2024Q3 from 708,609 million in 2024Q2 representing a change of 2.3%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 10,490 million in 2024Q3 from 7,964 million in 2024Q2 representing a change of 31.71%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 365,734 million in 2024Q3 from 369,097 million in 2024Q2 representing a change of -0.91%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 31,789 in 2024Q3 from 31,478 in 2024Q2 representing a change of 0.99%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 329,820 million in 2024Q3 from 318,532 million in 2024Q2 representing a change of 3.54%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 991,167 million in 2024Q3 from 972,986 million in 2024Q2 representing a change of 1.87%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 72,058 million in 2024Q3 from 78,760 million in 2024Q2 representing a change of -8.51%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 573,219 million in 2024Q3 from 591,655 million in 2024Q2 representing a change of -3.12%. This indicates a worsen liquidity position.

  Total Debt: Total Debt increased to 676,202 million in 2024Q3 from 644,299 million in 2024Q2 representing a change of 4.95%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	936851000	-16636538000	105.63
operating cash flow	14476456000	18718762000	-22.66
free cash flow	-27891380000	-14768718000	-88.85
capital expenditure	-42367836000	-33487480000	-26.52
depreciation and amortization	14480754000	15671969000	-7.60
deferred income tax	0	0	NaN
stock based compensation	264144999	94116000	180.66
accounts payables	20259099000	20233631000	0.13
inventory	-22106446000	-19292166000	-14.59
acquisitions net	7614551000	-9614315000	179.20
investments in property plant and equipment	-41302400000	-33487480000	-23.34
net cash used for investing activites	-55309897000	-68812125000	19.62
debt repayment	39830999000	63837128000	-37.61
common stock issued	11442000	8513000	34.41
common stock repurchased	0	-688285000	100.00
dividends paid	-9341869000	-8182808000	-14.16
net cash used provided by financing activities	41690637000	34681143000	20.21
cash at end of period	74784222000	73847371000	1.27
accounts receivables	-4752733000	-14509697000	67.24
cash at beginning of period	73847371000	90483909000	-18.39

Overall Score of Annual Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 937 million in 2023 from -16,637 million in 2022 representing a change of 105.63%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -42,368 million in 2023 from -33,487 million in 2022 representing a change of -26.52%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 14,476 million in 2023 from 18,719 million in 2022 representing a change of -22.66%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -27,891 million in 2023 from -14,769 million in 2022 representing a change of -88.85%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 264 million in 2023 from 94 million in 2022 representing a change of 180.66%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 20,259 million in 2023 from 20,234 million in 2022 representing a change of 0.13%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -4,753 in 2023 from -14,510 million in 2022 representing a change of 67.24%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -9,342 million in 2023 from -8,183 million in 2022 representing a change of -14.16%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	3621369000	234955000	1441.30
free cash flow	-8011793000	-18386711000	56.43
capital expenditure	-11633162000	-18621666000	37.53
depreciation and amortization	4379306000	4336359000	0.99
deferred income tax	0	0	NaN
stock based compensation	48455000	0	NaN
accounts receivables	1600881000	-19139044000	108.36
accounts payables	0	2367597000	-100.00
inventory	-1994669000	-3919381000	49.11
acquisitions net	-24898066000	-3111413000	-700.22
investments in property plant and equipment	-11633162000	-18621666000	37.53
net cash used for investing activites	-36632941000	9163315000	-499.78
debt repayment	32829656000	-1606132000	2144.02
common stock issued	2210508000	-360000	614130.00
common stock repurchased	0	0	NaN
dividends paid	-3780783000	368701000	-1125.43
net cash used provided by financing activities	28686457000	-2677338000	1171.45
net change in cash	-4649961000	-924509000	-402.97
cash at end of period	72057965000	78759593000	-8.51
cash at beginning of period	76707926000	79684102000	-3.73

Overall Score of Quarterly Cashflow Statement

0.38 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -4,650 million in 2024Q3 from -925 million in 2024Q2 representing a change of -402.97%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -11,633 million in 2024Q3 from -18,622 million in 2024Q2 representing a change of 37.53%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 48 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 1,601 in 2024Q3 from -19,139 million in 2024Q2 representing a change of 108.36%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -3,781 million in 2024Q3 from 369 million in 2024Q2 representing a change of -1125.43%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 3,621 million in 2024Q3 from 235 million in 2024Q2 representing a change of 1441.3%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -8,012 million in 2024Q3 from -18,387 million in 2024Q2 representing a change of 56.43%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q3 from 2,368 million in 2024Q2 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	526.56	436.72	20.57
net income per share	58.64	74.06	-20.82
operating cash flow per share	22.3	30.22	-26.22
free cash flow per share	-42.96	-23.84	-80.16
cash per share	128.63	143.24	-10.20
book value per share	1039.49	961.05	8.16
tangible book value per share	977.29	888.47	10.00
shareholders equity per share	610.72	592.59	3.06
interest debt per share	999.18	1033.56	-3.33
market cap	388209664915.2	400006675328	-2.95
enterprise value	933974715915.2	940487353328	-0.69
pe ratio	10.2	8.72	16.94
price to sales ratio	1.14	1.48	-23.21
pocfratio	26.82	21.37	25.49
pfcf ratio	-13.92	-27.08	48.61
pb ratio	0.98	1.09	-10.16
ptb ratio	0.98	1.09	-10.16
ev to sales	2.73	3.48	-21.43
enterprise value over ebitda	8.69	10.04	-13.46
ev to operating cash flow	64.52	50.24	28.41
ev to free cash flow	-33.49	-63.68	47.42
earnings yield	0.1	0.11	-14.48
free cash flow yield	-0.07	-0.04	-94.59
debt to equity	1.56	1.67	-6.50
debt to assets	0.39	0.42	-7.16
net debt to ebitda	5.08	5.77	-12.00
current ratio	1.65	1.75	-6.05
interest coverage	3.01	3.08	-2.45
income quality	0.22	0.36	-37.79
dividend yield	0.02	0.02	17.63
payout ratio	0.25	0.18	37.56
sales general and administrative to revenue	0.1	0.02	376.43
research and ddevelopement to revenue	0.0	0.0	64.50
intangibles to total assets	0.03	0.03	-17.44
capex to operating cash flow	2.93	1.79	63.59
capex to revenue	0.12	0.12	0.10
capex to depreciation	2.93	2.14	36.93
stock based compensation to revenue	0.0	0.0	122.06
graham number	897.63	993.7	-9.67
roic	0.05	0.06	-6.32
return on tangible assets	0.02	0.03	-24.14
graham net net	-954.72	-919.98	-3.78
working capital	226132553000	232767483000	-2.85
tangible asset value	634557499000	550341685000	15.30
net current asset value	-358276443000	-341463852000	-4.92
invested capital	439069318000	414700160000	5.88
average receivables	149371162000	156506850500	-4.56
average payables	127084269000	114976813500	10.53
average inventory	230959355000	183961990500	25.55
days sales outstanding	142.56	222.91	-36.05
days payables outstanding	220.42	210.46	4.73
days of inventory on hand	432.36	349.31	23.78
receivables turnover	2.56	1.64	56.36
payables turnover	1.66	1.73	-4.52
inventory turnover	0.84	1.04	-19.21
roe	0.1	0.12	-23.17
capex per share	65.25	54.06	20.70

• ROE:

  Debt-to-Equity Ratio:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 10.20 on 2023-12-31 from 8.72 on 2022-12-31, representing a change of 16.94%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.65 on 2023-12-31 from 1.75 on 2022-12-31, representing a change of -6.05%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
AYALY
calendar year	2024	2024	NaN
revenue per share	0	142.76	-100.00
net income per share	0	14.19	-100.00
operating cash flow per share	0	0.36	-100.00
free cash flow per share	0	-28.33	100.00
cash per share	0	133.6	-100.00
book value per share	0	1087.08	-100.00
tangible book value per share	0	1024.51	-100.00
shareholders equity per share	0	650.54	-100.00
interest debt per share	0	1005.29	-100.00
market cap	0	364428768038.4	-100.00
enterprise value	604143712000	929968038038.4	-35.04
pe ratio	0	9.89	-100.00
price to sales ratio	0	3.93	-100.00
pocfratio	0	1551.06	-100.00
pfcf ratio	0	-19.82	100.00
pb ratio	0	0.86	-100.00
ptb ratio	0	0.86	-100.00
ev to sales	7.92	10.03	-21.03
enterprise value over ebitda	18.64	40.84	-54.35
ev to operating cash flow	166.83	3958.07	-95.79
ev to free cash flow	-75.41	-50.58	-49.09
earnings yield	None	0.03	NaN
free cash flow yield	0	-0.05	100.00
debt to equity	1.55	1.53	1.91
debt to assets	0.39	0.38	2.66
net debt to ebitda	18.64	24.83	-24.93
current ratio	1.57	1.6	-2.23
interest coverage	1.33	0	NaN
income quality	0.19	0.01	1396.08
dividend yield	None	0.0	NaN
payout ratio	0.32	0.04	709.03
sales general and administrative to revenue	0.13	0.17	-23.85
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.02	0.02	-2.51
capex to operating cash flow	3.21	79.26	-95.95
capex to revenue	0.15	0.2	-24.06
capex to depreciation	2.66	4.29	-38.14
stock based compensation to revenue	0.0	0	NaN
graham number	0	455.8	-100.00
roic	0.01	0	NaN
return on tangible assets	0.01	0.01	23.91
graham net net	0	-955.37	100.00
working capital	207485009000	222557772000	-6.77
tangible asset value	684395823000	665045889000	2.91
net current asset value	-417947891000	-381331569000	-9.60
invested capital	449152273000	460612129000	-2.49
average receivables	86772092500	169551623500	-48.82
average payables	144164528500	142734529500	1.00
average inventory	254590053499.5	255373853499.5	-0.31
days sales outstanding	0	168.54	-100.00
days payables outstanding	234.18	227.5	2.94
days of inventory on hand	392.42	421.59	-6.92
receivables turnover	0	0.53	-100.00
payables turnover	0.38	0.4	-2.85
inventory turnover	0.23	0.21	7.43
roe	0.03	0.02	23.08
capex per share	0	28.69	-100.00

• Negative

  ROE: Return on Equity (ROE) increased to 0.03 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of 23.08%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 0.00 on 2024-09-30 Q3 from 9.89 on 2024-06-30 Q2, representing a change of -100.00%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.57 on 2024-09-30 Q3 from 1.60 on 2024-06-30 Q2, representing a change of -2.23%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Debt-to-Equity Ratio:

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None